| 摘要 |
The present invention encompasses novel triterpene compounds of general Formula (I) wherein RN1, RN2, R11a, R11b, R4, R17, R19 and R20 are defined as in claim 1, which exhibit an antiviral effect and are therefore suitable for the treatment of diseases related thereto and the use thereof for preparing a medicament having the above-mentioned properties. |
| 申请人 |
SAVIRA PHARMACEUTICALS GMBH;ONEPHARM RESEARCH & DEVELOPMENT GMBH;CLASSEN-HOUBEN, DIRK;KUEENBURG, BERNHARD;KOSMA, PAUL;JORDIS, ULRICH;STANETTY, CHRISTIAN;SZOLAR, OLIVER;WOLKERSTORFER, ANDREA |
发明人 |
CLASSEN-HOUBEN, DIRK;KUEENBURG, BERNHARD;KOSMA, PAUL;JORDIS, ULRICH;STANETTY, CHRISTIAN;SZOLAR, OLIVER;WOLKERSTORFER, ANDREA |
